| Drossapharm AG - Rivarax 15 mg, Filmtabletten | | 69032 | | 02 | | Rivarax 15 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 29.01.2024 | | |
| | Composition | | rivaroxabanum 15.0 mg, lactosum monohydricum 86.08 mg, cellulosi pulvis, crospovidonum Typ A, crospovidonum Typ B, copovidonum, natrii laurilsulfas corresp. natrium 0.12 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 15 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivaroxabanum | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Cellulosi Pulvis | | | | Copovidonum | | | | Crospovidonum typ A | | | | Crospovidonum typ B | | | | E 171 | | color. | | E 172 | | color. | | Lactose Monohydrate | 86.08 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 10 | 6.66 | 16.50 | B | LS | Non | | 005 | 30 | 19.52 | 37.60 | B | LS | Non | | 006 | 100 | 68.19 | 90.65 | B | LS | Non |
|
|
